Phio Pharmaceuticals Corp (NASDAQ:PHIO) price closed lower on Tuesday, January 14, and dropping -45.76% below its previous close.
A look at the daily price movement shows that the last close reads $6.60, with intraday deals fluctuated between $3.14 and $4.77. The company’s 5Y monthly beta was ticking 1.465. Taking into account the 52-week price action we note that the stock hit a 52-week high of $10.35 and 52-week low of $1.53. The stock added 32.59% on its value in the past month.
Phio Pharmaceuticals Corp, which has a market valuation of $6.20 million, is expected to release its quarterly earnings report in February.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give PHIO a short term outlook of 50% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Sell, while an average of long term indicators are currently assigning the stock as Hold.
The overview shows that PHIO’s price is at present 50.45% off the SMA20 and 38.22% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 55.97, with weekly volatility standing at 42.67%. The indicator jumps to 24.79% when calculated based on the past 30 days. Phio Pharmaceuticals Corp (NASDAQ:PHIO)’s beta value is holding at 1.19, while the average true range (ATR) indicator is currently reading 1.02.
An analysis of the Phio Pharmaceuticals Corp (NASDAQ:PHIO) stock in terms of its daily trading volume indicates that the 3-month average is 4.91 million. However, this figure increases on the past 10-day timeline to an average of 28.33 million.
Current records show that the company has 1.73M in outstanding shares. The insiders’ percentage holdings are 3.05% of outstanding shares while the percentage share held by institutions stands at 7.95%. The stats also highlight that short interest as of 2024-10-31, stood at 51491.0 shares, which puts the short ratio at the time at 0.5. From this we can glean that short interest is 600.00 of company’s current outstanding shares. Notably, we see that shares short in October rose slightly given the previous month’s figure stood at 48277.0. But the 98.89% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
